Evidence map›Paper›PMID 35832384›Full record

ArticleFrontiers in cellular and infection microbiology2022

Effects of Exosomes Derived From

Masoumeh Ebadi Zahmatkesh, Mariyeh Jahanbakhsh, Negin Hoseini, Saina Shegefti, Amir Peymani, Hossein Dabin, Rasoul Samimi, Shahin Bolori

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 38 citations in OpenAlex.

  1. Beyond the Stomach: Exploring the Role ofExpert reviews in molecular medicine · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Glucolipid Metabolic Disorders andInternational journal of endocrinology · 2026
    Review
  8. Evaluation ofIranian journal of microbiology · 2025
    Article
  9. Review
  10. Extracellular vesicles of Gram-negative and Gram-positive probiotics.Journal of microbiology (Seoul, Korea) · 2025
    Review
  11. Anticancer Effects ofIranian journal of public health · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Outer membrane vesicles ofFrontiers in microbiology · 2025
    Review
  16. Review
  17. Anticancer Effects ofReports of biochemistry & molecular biology · 2024
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Masoumeh Ebadi ZahmatkeshMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Mariyeh JahanbakhshMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Negin HoseiniMicrobiology Department, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Saina ShegeftiMicrobiology Department, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amir PeymaniMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Hossein DabinMicrobiology Department, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rasoul SamimiMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Shahin BoloriMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Qazvin University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver fibrosis is a multifactorial disease with microbial and non-microbial causes. In recent years,

Indexed as

ExosomesHelicobacter InfectionsHelicobacter pyloribeta CateninCadherinsHepatic Stellate CellsHepatocytesHumansLiver CirrhosisTissue Inhibitor of Metalloproteinase-1Vimentinbeta CateninCadherinsTissue Inhibitor of Metalloproteinase-1VimentinexosomeHelicobacter pyloriliver fibrosisouter membrane vesicleα-SMA

Identifiers

PMID35832384
PMCPMC9271900
OpenAlexW4283578286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.